Has Habib Samady, MD received payments from drug or device companies?

Yes. Drug and device makers reported $42,225 in general payments to Habib Samady, MD across 116 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Habib Samady, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Habib Samady, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Habib Samady, MD

Interventional Cardiology · Gainesville, GANPI 1043287832

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $27,125 of the $42,225 with a category attached, or 64.2%. Philips North America LLC accounts for 87.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $15,706 and has fallen 99.5% since, to $75 in 2025.

$42,225in general payments, 2019–2025

Across 116 payments — averaging $364.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Philips North America LLC$37K
Abbott$3K
Edwards Lifesciences$629
Medtronic$392
Boston Scientific$276
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$242
plus $602 from 8 others

$341,564in research payments, 2019–2025

Across 39 payments — averaging $8758.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$156K
Abbott$123K
Gilead$62K

What the payments were for

Consulting fees$27,12564%
Speaking & faculty fees$6,40015%
Travel & lodging$4,58211%
Food & beverage$4,11810%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Philips North America LLC	44	$37,096
Abbott	15	$2,988
Edwards Lifesciences	14	$629
Medtronic(2 entities)	13	$392
Boston Scientific	5	$276
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	13	$242
Shockwave Medical, Inc	3	$191
Inari Medical, Inc.	2	$119
Artivion, Inc.	1	$102
Terumo Medical Corporation	2	$97
Getinge USA Sales, LLC	1	$24
AstraZeneca	1	$24
Kestra Medical Technology Services, Inc.	1	$23
Amgen	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

(9520) IGT Devices Undivided$29,788
Spectranetics Undiv$6,400
Xience V coronary stent system$1,206
OPTIS$1,200
Resolute$143
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$138
XIENCE SKYPOINT$117
(6574) Coronary Other$114
Dragonfly OCT$105
ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER$102
BIOGLUE SURGICAL ADHESIVE$102
CRYOVALVE SG PULMONARY HUMAN HEART VALVE$102
AMDS-Ascyrus Medical$102
GENERAL - THERAPIES$101

How this compares

$42,225 in reported general payments places this provider in the 80th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia →

Medicare billing

Part B allowed, 2024

$13,171

Medicare patients

Services billed

122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Repatha SureclickEvolocumab	17	$11,455
Metoprolol Succinate	37	$549
ClopidogrelClopidogrel Bisulfate	30	$347
Rosuvastatin Calcium	22	$312
Ezetimibe	15	$307
Atorvastatin Calcium	24	$211
Losartan Potassium	24	$122
Pantoprazole Sodium	12	$108
Amlodipine Besylate	28	$95
Carvedilol	20	$50
Spironolactone	11	$44
Furosemide	13	$32
Metoprolol Tartrate	15	$32

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Gainesville

Mudassar AhmedGainesville$193K
Stephane RinfretGainesville$72K
Ronnie RamadanGainesville$45K
Zachary GeorgeGainesville$24K
Olga TolevaGainesville$19K
Marc Allard-RatickGainesville$19K
William NicholsonAtlanta$1000K
David KandzariAtlanta$982K
Pradeep YadavAtlanta$656K
Salvatore ManninoMarietta$275K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →